Done Global Arrests Will Cast A Long Shadow on Behavioral Health

The arrests of Done Global executives could not have come at a worse time for the industry. Granted, there is never a good time for such an event. It just so happens that, right now, the arrests of executives of the heavily scrutinized digital ADHD treatment provider could play heavily in how several unresolved industry […]

DEA Close to Unveiling New Telehealth Regulations for Controlled Substance Prescriptions

The Drug Enforcement Administration is preparing to release its final rule for telehealth and controlled substances. On Thursday, the White House’s Office of Management and Budget (OMB) received the final rule from the DEA. The OMB oversees the coordination and review of major executive branch actions. It’s the final stop before the final rules are […]

DEA Extends Telehealth Flexibilities Another Year

The federal government will extend COVID-era telehealth flexibilities until December 2024, dramatically extending the runway for the Drug Enforcement Administration (DEA) to establish new rules for using telehealth and controlled substances. The DEA and U.S. Department of Health and Human Services released a new temporary rule on Oct. 6 after conducting two days of listening […]

What DEA Leaders Are Saying About Telehealth and Prescribing Controlled Substances

Key Drug Enforcement Administration (DEA) leaders said little last week during the roughly 11 hours of live presentations heard over two days of listening sessions regarding the future of telehealth and prescribing controlled substances. What they did say, however, helps clarify what is top of mind for the DEA as the agency considers re-approaching how […]

‘They Won’t Rip Telehealth Away’: Digital Behavioral Health Companies Prepare for Industry-Shaping DEA Decision

November is fast approaching, and with it comes the Drug Enforcement Administration’s (DEA) proposed rule on telehealth and controlled substance prescribing. After a six-month delay, the federal law enforcement and regulatory body will release regulations that will shape the future of telehealth within behavioral health in the post-COVID era. It also has the potential to […]

‘We Consider This To Be Our New Normal’: Behavioral Health Leaders Go To Bat for Telehealth Prescribing in Front of DEA

Several behavioral health executives shared their thoughts on the Drug Enforcement Administration’s (DEA) proposed rules for controlled substances and telehealth on Tuesday, with most going to bat for virtual-prescribing practices in front of agency officials. Tuesday brought the first of two listening sessions to discuss what potential post-COVID regulations for telehealth prescribing could and should […]

DEA ‘Open To Considering’ Special Registration Process for Telehealth Controlled Substance Prescribing

The Drug Enforcement Administration (DEA) has openly signaled a reversal in its stance towards a long-mandated special registration process that would allow telehealth prescribing of certain controlled substances. In a newly published meeting notice, the DEA says the voluminous and negative feedback on its proposed rule for post-public health emergency telehealth regulations inspired its new […]

DEA Extends Telehealth Flexibilities 6 Months in a Win for Behavioral Health Advocates

The Drug Enforcement Administration (DEA) released a temporary rule extending COVID-era telehealth flexibilities from the end of the public health emergency (PHE) on May 11 to Nov. 11, 2023. The extension allows clinicians prescribing controlled substances over telehealth to continue to do so for another six months. Patients that initiate care on or before Nov. […]

‘We Recognize the Importance of Telemedicine’: DEA Administrator Shares New Details on Agency’s Final Rule

The Drug Enforcement Administration confirmed that it will extend COVID-era telehealth flexibilities. On Wednesday, the agency said it needs additional time to work through the mountain of comments it received on two rules that would claw back telehealth and controlled substance prescribing flexibilities. “We take those comments seriously and are considering them carefully,” DEA Administrator […]

DEA Delays Ending Controlled-Substances Prescribing Flexibilities, Buys More Time for Virtual MAT Providers

The Drug Enforcement Administration appears to have filed for a temporary extension of telehealth flexibilities beyond the public health emergency. This reflects an apparent reaction on the part of the DEA to the major backlash it faced during the public comment period for two rules it release that would reestablish austere restrictions on accessing treatment […]